Human Cancer Protein-Protein Interaction Network: A Structural Perspective
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Protein-protein interaction networks provide a global picture of cellular function and biological processes. Some proteins act as hub proteins, highly connected to others, whereas some others have few interactions. The dysfunction of some interactions causes many diseases, including cancer. Proteins interact through their interfaces. Therefore, studying the interface properties of cancer-related proteins will help explain their role in the interaction networks. Similar or overlapping binding sites should be used repeatedly in single interface hub proteins, making them promiscuous. Alternatively, multi-interface hub proteins make use of several distinct binding sites to bind to different partners. We propose a methodology to integrate protein interfaces into cancer interaction networks (ciSPIN, cancer structural protein interface network). The interactions in the human protein interaction network are replaced by interfaces, coming from either known or predicted complexes. We provide a detailed analysis of cancer related human protein-protein interfaces and the topological properties of the cancer network. The results reveal that cancer-related proteins have smaller, more planar, more charged and less hydrophobic binding sites than non-cancer proteins, which may indicate low affinity and high specificity of the cancer-related interactions. We also classified the genes in ciSPIN according to phenotypes. Within phenotypes, for breast cancer, colorectal cancer and leukemia, interface properties were found to be discriminating from non-cancer interfaces with an accuracy of 71%, 67%, 61%, respectively. In addition, cancer-related proteins tend to interact with their partners through distinct interfaces, corresponding mostly to multi-interface hubs, which comprise 56% of cancer-related proteins, and constituting the nodes with higher essentiality in the network (76%). We illustrate the interface related affinity properties of two cancer-related hub proteins: Erbb3, a multi interface, and Raf1, a single interface hub. The results reveal that affinity of interactions of the multi-interface hub tends to be higher than that of the single-interface hub. These findings might be important in obtaining new targets in cancer as well as finding the details of specific binding regions of putative cancer drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Representation of PIN,SPIN and iSPIN. In A) proteins in PIN are represented; the ones colored black have PDB IDs and the ones colored blue do not have PDB IDs. In B) The proteins with PDB ID and interactions among them constitutes SPIN. In C) The proteins with PDB ID and protein interface information and their interactions constitutes iSPIN. The zoomed representations give idea about what type of information each network contains; PIN is an abstract representation of interactions, SPIN is a subset of PIN with information of PDB IDs, and iSPIN contains the most detailed information including protein interfaces into network. All the networks are visualized using Cytoscape [76].](https://figures.cochat.ai/paper-figures/2bf731c1fa9c4785ae1df0d0e817ce26/human-cancer-protein-protein-interaction-network-a-structural-perspective-figure-1.jpg)






![Figure 8 Representation of ERBB3-NRG1 interaction schematically. The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively. The transparent surface represents the interface region. The labeled residues (represented by their Cα atoms) of 1hae_A are reported to be critical for binding in a previous work [58]; i.e. when they are mutated to alanine, the binding affinity for ERBB3 was significantly reduced. B) HER3 (blue) – pertuzumab heavy chain (yellow) is shown. Pertuzumab shares the same interface with NRG1 (see “An inhibitor affecting Erb signaling pathway: pertuzumab” section).](https://figures.cochat.ai/paper-figures/57ca480593bb41beab9a8e93528906ac/human-cancer-protein-protein-interaction-network-a-structural-perspective-figure-8.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, cancer-related proteins often interface with their binding partners using distinct surfaces, corresponding typically to multi-interface hub [21].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [21]
In the citing paper
“Deeper investigations of protein-protein interfaces relevant to human oncogenesis and cancer-associated protein-protein interaction networks have shown that cancer-related proteins are smaller, more planar, more charged, and less hydrophobic binding sites than non-cancer-related proteins and they tend to show lower affinity and higher specificity for cancer-associated PPI networks.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · cited 1×
“They used an orthology-based method in which BLAST [65] searches were run for the human genome against all proteins in the DIP [59] and MIPS Mammalian Protein-Protein Interaction databases [66].”
MethodVMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952 · cited 1×
“The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively.”
MethodCytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“All the parameters describing the network topology were calculated using NetworkAnalyzer, which is a Java plugin for Cytoscape [76].”
MethodBerman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · cited 2×
“According to the KEGG database [56], ERBB3 functions in the ErbB signaling pathway and the Calcium signaling pathway.”
BackgroundMethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Community structure in social and biological networks
Girvan, M., & Newman, M. E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122653799 · Cited by 15,502 · cited 1×
“Betweenness is a measure of the total number of shortest paths going through a certain node or edge in the network [69].”
BackgroundNetwork biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 3×
“In Figure 2B, the average clustering coefficient, which is a measure of proteins to form clusters in the network [42] is shown.”
BackgroundInfluentialAn automated method for finding molecular complexes in large protein interaction networks
Bader, G. D., & Hogue, C. W. (2003) · BMC Bioinformatics · doi:10.1186/1471-2105-4-2 · Cited by 6,072 · cited 2×
“Here, we performed a clustering analysis of SPIN using MCODE [44] and obtained subnetworks (see Methods).”
MethodLethality and centrality in protein networks
Jeong, H., Mason, S. P., Barabási, A.-L., & Oltvai, Z. N. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,287
Cited by
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
“Cancer-related proteins have smaller, more planar, more charged and less hydrophobic binding interfaces than other proteins, which may indicate low affinity and high specificity of cancer-related interactions (Kar et al., 2009).”
BackgroundPredicting Protein–Protein Interactions from the Molecular to the Proteome Level
Keskin, O., Tuncbag, N., & Gursoy, A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00683 · Cited by 369
ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage
Bensimon, A., Schmidt, A., Ziv, Y., Elkon, R., Wang, S.-Y., Chen, D. J., Aebersold, R., & Shiloh, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2001034 · Cited by 280
“Most of the nodes in this network had only few edges, whereas a few nodes, termed “hubs,” had more edges than the average and probably represent key players (50, 51, 53).”
BackgroundTuncbag, N., Gursoy, A., Nussinov, R., & Keskin, O. (2011) · Nature Protocols · doi:10.1038/nprot.2011.367 · Cited by 263
“PRISM has been used in several studies including comparison of physicochemical properties of cancer-related protein complexes on a large scal”
MethodHive plots--rational approach to visualizing networks
Krzywinski, M., Birol, I., Jones, S. J., & Marra, M. A. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr069 · Cited by 224
“[5, 17].”
Background
Metadata
- Authors
- Kar, G., Gursoy, A., & Keskin, O.
- Affiliations
- Koç University (TR)
- ORCID
- Kar, Gozde
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-11
- Volume
- 5
- Issue
- 12
- Pages
- e1000601
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC2785480
- OpenAlex
- W2150066952
- Cited by
- 235
- References
- 83
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 12 · 2020: 7 · 2019: 17 · 2018: 9 · 2017: 26 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 28 · 2012: 17
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Collections portal (Koç University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (104T504)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- protein-protein interaction network, cancer-related proteins, protein interfaces, binding sites, hub proteins, network topology, binding affinity, binding specificity, breast cancer, colorectal cancer, leukemia, HER3, Raf-1, cancer drug targets
- MeSH terms
- Animals, Binding Sites, Humans, Models, Molecular, Neoplasms, Protein Binding, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Computational Biology, Protein Interaction Domains and Motifs, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Cancer Protein-Protein Interaction Network: A Structural Perspective. https://app.cochat.ai/papers/10.1371/journal.pcbi.1000601
- The paper
- Kar, G., Gursoy, A., & Keskin, O. (2009). Human Cancer Protein-Protein Interaction Network: A Structural Perspective. PLoS Computational Biology. https://doi.org/10.1371/journal.pcbi.1000601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.